Post hoc analysis of CONVINCE (3144 participants after non-cardioembolic stroke): colchicine plus usual care vs usual care did not significantly reduce MACE in those with atherosclerosis (11.1% vs 14.2%; HR 0.83, 95% CI 0.64-1.07) or without (HR 0.94); no significant interaction.
Secondary analysisn = 3,144
McCabe et al. Colchicine for Secondary Prevention After Stroke According to the Presence of Atherosclerosis